Ayala Pharmaceuticals, Inc. (ADXS) has 20 known insider and institutional holders on record. The largest holder is ADAGE CAPITAL PARTNERS GP LLC with 5,743,184 shares. Other notable holders include ADAGE CAPITAL PARTNERS GP, L.L.C. and Israel Biotech Fund I, L.P..
ADXS Insider Ownership
Top Holder
ADAGE CAPITAL PARTNERS GP LLC
5,743,184 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Adage Capital Partners Gp Llc |
10 Percent Owner |
5,743,184 |
2015-08-24 |
|
| 2 |
Adage Capital Partners Gp, L.l.c. |
10 Percent Owner |
4,100,043 |
2017-10-12 |
|
| 3 |
Israel Biotech Fund I, L.p. |
10 Percent Owner |
4,087,500 |
2024-03-06 |
|
| 4 |
Rothman John F |
Exec VP of Science and Ops |
3,000,000 |
2011-11-10 |
|
| 5 |
Cobb Fredrick D |
Vice President Finance |
1,450,000 |
2009-08-07 |
|
| 6 |
Low Nathan A |
10 Percent Owner |
719,511 |
2004-12-10 |
|
| 7 |
Cabilly Yuval |
Director |
621,253 |
2023-11-08 |
|
| 8 |
O'connor Daniel |
Chief Executive Officer |
618,352 |
2017-07-03 |
|
| 9 |
Amoon Growth Fund Limited Partnership |
10 Percent Owner |
560,602 |
2023-10-23 |
|
| 10 |
Bonstein Sara |
Chief Financial Officer |
226,670 |
2018-04-03 |
|
| 11 |
Moore Thomas A |
Officer |
176,462 |
2014-07-18 |
|
| 12 |
Mauro David J |
Chief Medical Officer |
166,271 |
2016-01-04 |
|
| 13 |
Petit Robert |
Chief Scientific Officer |
150,000 |
2018-11-07 |
|
| 14 |
Rosenblum Mark J |
Chief Financial Officer |
113,774 |
2014-02-04 |
|
| 15 |
Mayes, Gregory T. |
Director |
103,841 |
2017-01-03 |
|
| 16 |
Lombardo Anthony A |
Interim CEO |
81,852 |
2018-04-18 |
|
| 17 |
French Christy Lee |
VP-regulatory, Medical Affairs |
71,938 |
2015-01-02 |
|
| 18 |
Berlin Kenneth A |
President and CEO |
50,000 |
2020-05-05 |
|
| 19 |
Gutierrez Andres |
Executive Vice President & CMO |
50,000 |
2020-05-05 |
|
| 20 |
Henderson Molly |
Executive Vice President & CFO |
50,000 |
2020-05-05 |
|
No ownership data available for ADXS.
